Active, Not Recruiting
Pembrolizumab and Chemotherapy Neoadjuvant/Adjuvant of NSCLC
NCT05894889
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
- Locations
-
- Peking University Beijing, Beijing Municipality, China
- Shanghai Pulmonary Hospital Shanghai, Shanghai Municipality, China